Clinical Trials on GH Deficiency (GHD)

Total 9313 results

Azidus Brasil

Unknown

Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.

Growth Retardation | GH Deficiency (GHD)

Brazil
Eli Lilly and Company

Completed

Observational Study of Somatropin Treatment in Children (GeNeSIS)

Growth Hormone (GH) Deficiency | Short Stature Homeobox Containing Gene (SHOX) Deficiency | SHOX Deficiency-related Disorder | Non-GH-deficient Growth Disorders
Guangzhou First People's Hospital

Unknown

To Explore the Effect of GH Pretreatment on Clinical Outcomes in Patients With Low Ovarian Reserve

Low Ovarian Reserve | GH
Guangzhou First People's Hospital

Unknown

To Explore the Effect of GH on Outcomes of IVF and Telomerase Activity of Granulosa Cells in Women With POR

GH | Poor Ovarian Reserve Based on POSEIDON
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency (ESCALATE)

GHD
OPKO Health, Inc.

Completed

Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Growth Hormone Deficiency (GHD)

United States, Belarus, Greece, Hungary, Russian Federation, Ukraine
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency (ELEVATE)

GHD

United States
Herlev Hospital

Unknown

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

Interaction Between the GH/IGF-I System and the Immune-system

Denmark
LG Life Sciences
BioPartners GmbH

Unknown

Treatment of Children With Insufficient Secretion of Growth Hormone (BPLG-004)

Growth Hormone Deficiency (GHD)

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Evaluation of Somatostatin Receptors and GH Receptor Expression on Bone of Acromegalic Patients (ACRO-BONE) (ACRO-BONE)

Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients

Italy
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Bioavailability Study of Two Different PEG-rhGH Preparations.

Pediatric Growth Hormone Deficiency (PGHD)

China
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

Pediatric Growth Hormone Deficiency (PGHD)

China
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Bioequivalence Study of Two Different PEG-rhGH Preparations.

Pediatric Growth Hormone Deficiency (PGHD)

China
Changchun GeneScience Pharmaceutical Co., Ltd.

Not yet recruiting

A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH Preparations

Pediatric Growth Hormone Deficiency (PGHD)

China
EMD Serono

Terminated

Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study

Growth Hormone Deficiency (GHD)

United States
Ascendis Pharma A/S

Completed

Safety, PK/PD (Pharmacokinetics/Pharmacodynamics) and Efficacy of ACP-001 Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)

Growth Hormone Deficiency (GHD)

Egypt, Turkey, Germany, Poland, France, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria, Czech Republic, Greece, Romania, Slovenia
University of Jordan

Completed

Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio

Diagnosis of GHD With IGF-I/IGFBP-3 Ratio
Rabin Medical Center

Recruiting

Effect of Nutritional Formula Supplementation on Growth Rate of Growth Hormone (GH) Treated Children With Growth Hormone Deficiency (GHD) After the Second Year of Therapy

Growth Retardation | IGHD - Isolated Growth Hormone Deficiency

Israel
Shanghai Jiao Tong University School of Medicine

Completed

PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

GVHD, Acute

China
Mats Remberger
The Swedish Research Council

Recruiting

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT (2017-00355)

GVHD, Acute

Sweden, Norway, Denmark
MaaT Pharma

Recruiting

Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013 (ORION)

Steroid Refractory GVHD | Intestinal GVHD

France
Versartis Inc.
Premier Research Group plc

Terminated

Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)

Adult Growth Hormone Deficiency (AGHD)
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Multiparametric Ultrasound Study in Diagnosing GvHD (ECO-STEM)

Intestinal GVHD

Italy
CSL Behring

Terminated

Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) (ALD518-010)

Acute GvHD

United States
Weill Medical College of Cornell University

Terminated

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Glucocorticosteroid Refractory Acute GVHD

United States
Federico II University

Completed

Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity (GH&LASGB)

Obesity | GHD

Italy
Nationwide Children's Hospital
Daisy Foundation

Completed

70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014 (70% EtOH)

GVHD | Hematopoietic Stem Cell Transplant

United States
Ciusss de L'Est de l'Île de Montréal
Centre hospitalier de l'Université de Montréal (CHUM)

Not yet recruiting

Improvement of Women's Health After Allogeneic Stem Cell Transplantation (SaFeGreff)

GVHD, Chronic
daphne brockington

Unknown

Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD (CARE)

Chronic GVHD After HCT for Cancer or Immune Disease

Canada
University of Salamanca

Recruiting

Physiotherapy and Therapeutic Exercise Program in Graft-versus-host Disease (GvHD)

GVHD, Chronic | GVHD,Acute

Spain
Duke University

Recruiting

Prebiotic Galacto-oligosaccharide and Acute GVHD

Acute GVHD

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

GVHD | Allogeneic Stem Cell Transplantation

Italy
Zhaoyun Zhang

Unknown

A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Pituitary Tumor

China
Genzyme, a Sanofi Company

Completed

Growth and Development Study of Alglucosidase Alfa

Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Pompe Disease

United States
European Society for Blood and Marrow Transplantation
Mallinckrodt

Completed

ECP Combination Study

Steroid Refractory GVHD

Spain, United Kingdom, Sweden, Italy, Israel, France, Denmark, Germany, Poland, Turkey, Romania, Belgium, Greece, Russian Federation
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...

Not yet recruiting

Safety and Efficacy Study of hAESCs Therapy for aGVHD (aGVHD，hAESCs)

GVHD,Acute
UNC Lineberger Comprehensive Cancer Center
University of North Carolina, Chapel Hill

Completed

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Acute GVHD

United States
Wang Xin

Not yet recruiting

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

GVHD

China
Hackensack Meridian Health

Terminated

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

GVHD

United States
Chen Li

Recruiting

Developmental Regression-related Disease Research and Achievement Transformation Innovation Team

ASD | GDD

China
Shenzhen Xbiome Biotech Co., Ltd.

Not yet recruiting

Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of GI-aGVHD

GVHD
University of Minnesota

Withdrawn

Allogeneic Skin Grafting

GVHD

United States
IRCCS Policlinico S. Matteo

Completed

Comparison of Two Automated Mononuclear Collection Systems in Patients Undergoing Extracorporeal Photochemotherapy. A Cross-over Equivalence Study. (MNC_CMNC) (CMNC_MNC)

GvHD | Lung Graft Dysfunction

Italy
Ossium Health, Inc.

Withdrawn

Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)

GVHD,Acute
Xuzhou Medical University

Recruiting

Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD

cGVHD

China
Chinese PLA General Hospital

Recruiting

Role of aGVHD Biomarkers on aGVHD Risks (GVHD)

Biomarker | GVHD,Acute

China
Genzyme, a Sanofi Company

Approved for marketing

Alglucosidase Alfa Temporary Access Program (ATAP)

Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)

United States
Rigshospitalet, Denmark
Novo Nordisk A/S

Completed

Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT (SIMPly-CARE)

Hematological Malignancy | GVHD, Chronic

Denmark
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Completed

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

GVHD | Graft-versus-host-disease | GVHD, Acute

United States
Equillium
Biocon Limited

Recruiting

A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR)

Graft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHD

United States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand

Clinical Trials on GH Deficiency (GHD)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations